435. Dr. Salim Yusuf

MBBS, MD (Bangalore), DPhil (Oxford), MRCP

Dr. Yusuf, a graduate of St. John's Medical College, Bangalore University, India, was awarded a Rhodes Scholarship that took him to Oxford where he completed a doctorate and underwent clinical training in cardiology. In 1984, he moved to the National Institutes of Health as a scientific project officer of several landmark studies (SOLVD, DIG, and the post-CABG studies) and as Chairman of the working group for the Women's Health clinical trial.

Dr. Yusuf became Acting Chief of the Clinical Trials Branch of the National Heart, Lung, and Blood Institute (NHLBI) and held a number of appointments at the Uniformed Services, University of Health Sciences. In 1992, Dr. Yusuf became Director of the Division of Cardiology, McMaster University, and Director of the Preventive Cardiology and Therapeutic Program, Hamilton Civic Hospitals Research Centre; in 1999, he became the Director of the Population Health Research Institute; he is also Professor of Medicine. Recently, he has been the principal investigator and chairman of several major trials such as HOPE, OASIS, RESOLVD, INTERHEART, SHARE, etc. Dr. Yusuf has conducted studies in Canada, India, and 50 other countries examining why individuals of different ethnic backgrounds experience different heart disease rates.

As Professor and Director of Cardiology he is also lead clinical investigator on the CURE study ( C lopidogrel in U nstable Angina to Prevent Recurrent Ischemic E vents), a large-scale international trial, investigating antiplatelet therapy in acute coronary syndrome.

He holds an endowed Chair for Research from the Heart and Stroke Foundation of Ontario and is a senior scientist of the Canadian Institute of Health Research. Dr. Yusuf has published more than 300 papers, and edits the Journal of Evidence-Based Cardiology and Textbook of Evidence-Based Cardiovascular Medicine.

Dr. Yusuf received many international awards in the areas of thrombolysis, antithrombotics, prevention of vascular diseases, congestive heart failure, and meta-analytic approaches to the evaluation of clinical trials. These include the Durrer Lecturer (1988), Professional of the Year, Indo-Canadian Chamber of Commerce (1996), NIH Group Award (1992), Sol Sherry Lecturer Award from the International Society of Thrombosis and Hemostasis (1999), Honorary fellowship of the Polish Cardiac Society 91995) and Venezuelan Cardiac Societies (1999), and the Research Achievement Award of the Canadian Cardiovascular Society (1999).

Dr. Yusuf has trained several researchers who are now active in several parts of the world.

Source : phri.ca